Javitt Jonathan C - Insider Non-Derivative Transactions at NRX Pharmaceuticals, Inc. (NRXP) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 17, 2024, Javitt Jonathan C's relationship to NRX Pharmaceuticals, Inc. (NRXP) is Director,Officer,TenPercentOwner (Chairman and Chief Scientist), and currently has 14,468,329 shares of Common Stock, par value $0.001 per share, and 84,634 shares of Common Stock.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NRXP insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Javitt Jonathan C - Insider Non-Derivative Transactions of NRXP Common Stock, par value $0.001 per share

Javitt Jonathan C - Insider Non-Derivative Transactions of NRXP Common Stock

Javitt Jonathan C - Insider Non-Derivative Transactions at NRXP

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 18, 2024	P -- (Common Stock)	40000	1.17	84634
Aug 24, 2023	P -- (Common Stock)	100000	0.33	446332
Aug 23, 2023	P -- (Common Stock)	200000	0.32	346332
Dec 15, 2022	G -- (Common Stock, par value $0.001 per share)	300000	0	14468329